# Republic Services, Inc.: overview

RSG · NYSE · CIK 1060391 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rsg.md) · [Financials](/companies/rsg/financials.md) · [Filings](/companies/rsg/filings.md) · [Insiders](/companies/rsg/insiders.md)

Latest reported revenue: [$4.43bn](/filings/0001060391-26-000275.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001060391-26-000275).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,076](/filings/0001628280-25-047655.md) | [4,046 d](/filings/0001060391-26-000094.md) | [4,009](/filings/0001060391-26-000212.md) | [4,235](/filings/0001060391-26-000275.md) | [4,212](/filings/0001628280-25-047655.md) | [4,135 d](/filings/0001060391-26-000094.md) | [4,113](/filings/0001060391-26-000212.md) | [4,430](/filings/0001060391-26-000275.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [20.8%](/filings/0001628280-25-047655.md) | [19.8% d](/filings/0001060391-26-000094.md) | [20.1%](/filings/0001060391-26-000212.md) | [20.3%](/filings/0001060391-26-000275.md) | [19.8%](/filings/0001628280-25-047655.md) | [19.3% d](/filings/0001060391-26-000094.md) | [20.2%](/filings/0001060391-26-000212.md) | [20.3%](/filings/0001060391-26-000275.md) |
| Net margin | % | [13.9%](/filings/0001628280-25-047655.md) | [12.7% d](/filings/0001060391-26-000094.md) | [12.3%](/filings/0001060391-26-000212.md) | [13.0%](/filings/0001060391-26-000275.md) | [13.1%](/filings/0001628280-25-047655.md) | [13.2% d](/filings/0001060391-26-000094.md) | [12.8%](/filings/0001060391-26-000212.md) | [12.8%](/filings/0001060391-26-000275.md) |
| Diluted EPS | $ per share | [1.80](/filings/0001628280-25-047655.md) | not reported | [1.58](/filings/0001060391-26-000212.md) | [1.75](/filings/0001060391-26-000275.md) | [1.76](/filings/0001628280-25-047655.md) | not reported | [1.70](/filings/0001060391-26-000212.md) | [1.84](/filings/0001060391-26-000275.md) |
| Free cash flow | $m | [549 d](/filings/0001628280-25-047655.md) | [524 d](/filings/0001060391-26-000094.md) | [566](/filings/0001060391-26-000212.md) | [702 d](/filings/0001060391-26-000275.md) | [737 d](/filings/0001628280-25-047655.md) | [404 d](/filings/0001060391-26-000094.md) | [751](/filings/0001060391-26-000212.md) | [761 d](/filings/0001060391-26-000275.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [11.3](/filings/0001060391-24-000142.md) | [13.5](/filings/0001060391-25-000091.md) | [15.0](/filings/0001060391-26-000094.md) | [16.0](/filings/0001060391-26-000094.md) | [16.6](/filings/0001060391-26-000094.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [18.4%](/filings/0001060391-24-000142.md) | [17.7%](/filings/0001060391-25-000091.md) | [18.6%](/filings/0001060391-26-000094.md) | [19.9%](/filings/0001060391-26-000094.md) | [19.9%](/filings/0001060391-26-000094.md) |
| Net margin | % | [11.4%](/filings/0001060391-24-000142.md) | [11.0%](/filings/0001060391-25-000091.md) | [11.6%](/filings/0001060391-26-000094.md) | [12.7%](/filings/0001060391-26-000094.md) | [12.9%](/filings/0001060391-26-000094.md) |
| Diluted EPS | $ per share | [4.04](/filings/0001060391-24-000142.md) | [4.69](/filings/0001060391-25-000091.md) | [5.47](/filings/0001060391-26-000094.md) | [6.49](/filings/0001060391-26-000094.md) | [6.85](/filings/0001060391-26-000094.md) |
| Free cash flow | $bn | [1.5](/filings/0001060391-24-000142.md) | [1.7](/filings/0001060391-25-000091.md) | [2.0](/filings/0001060391-26-000094.md) | [2.1](/filings/0001060391-26-000094.md) | [2.4](/filings/0001060391-26-000094.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rsg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.80bn | 17,824,725 |  | Added +945,478 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.78bn | 13,061,578 |  | Added +3,372 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.12bn | 9,953,507 |  | Added +160,051 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.52bn | 7,116,030 |  | Added +2,886,272 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $1.05bn | 4,905,312 |  | Reduced −129,866 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.04bn | 4,896,109 |  | Added +8,772 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $968.3m | 4,544,104 |  | Reduced −106,840 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $787.7m | 3,669,000 |  | Added +143,756 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $682.6m | 3,203,365 |  | Added +1,328,351 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $674.0m | 3,162,965 |  | New +3,162,965 |

## Recent filings

[All 2,846 filings](/companies/rsg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:10 ET | [8-K](/filings/0001060391-26-000326.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001060391-26-000326 |
| 2026-09-09 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-106327.md) | Ownership report, active investor, amended | 0001104659-26-106327 |
| 2026-08-20 | 16:25 ET | [SCHEDULE 13D/A](/filings/0001104659-26-099242.md) | Ownership report, active investor, amended | 0001104659-26-099242 |
| 2026-08-07 | 20:53 ET | [10-Q](/filings/0001060391-26-000275.md) | Quarterly report, period 2026-06-30 | 0001060391-26-000275 |
| 2026-08-06 | 16:08 ET | [8-K](/filings/0001060391-26-000273.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001060391-26-000273 |
| 2026-07-30 | 19:02 ET | [8-K](/filings/0001060391-26-000266.md) | 8.01 Other events | 0001060391-26-000266 |
| 2026-06-24 | 17:58 ET | [8-K](/filings/0001193125-26-279862.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-279862 |
| 2026-05-11 | 17:15 ET | [8-K](/filings/0001060391-26-000215.md) | 5.07 Shareholder vote results | 0001060391-26-000215 |
| 2026-05-08 | 21:28 ET | [10-Q](/filings/0001060391-26-000212.md) | Quarterly report, period 2026-03-31 | 0001060391-26-000212 |
| 2026-05-07 | 16:10 ET | [8-K](/filings/0001060391-26-000210.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001060391-26-000210 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001060391-26-000094.md), filed Feb 18, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/77fa938f-68c3-4e14-959c-2d049063777c)

## About the filer

- CIK: 1060391
- Tickers: RSG
- Exchange: NYSE
- SIC code: 4953 Refuse Systems
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 06:13 ET. No prices; not investment advice.